BioPharma Credit PLC (BOPCF) Stock
Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About BioPharma Credit PLC
Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.
BioPharma Credit PLC is headquartered in GB.
BioPharma Credit PLC (BOPCF) stock trades at $1.01 with a market capitalization of $1.15B. The stock is valued at a price-to-earnings (P/E) ratio of 8.43, price-to-book of 0.94, price-to-sales of 7.68. Over the past 52 weeks the stock has ranged between $0.85 and $1.02, and currently trades at its 52-week high. It pays a dividend yielding 3.96%.
On profitability, BioPharma Credit PLC generates a return on equity (ROE) of 11.29%, return on capital employed of 11.24%, an operating margin of 92.51%, a net profit margin of 92.62%.
Official website: www.bpcruk.com